Silo Pharma (SILO) FCF Margin (2019 - 2026)
Silo Pharma (SILO) posted FCF Margin of 4563.54% for Q1 2026, down 5.43% sequentially from 4328.63% in Q4 2025, and up 453610.0% YoY from N/an in Q1 2025.
Silo Pharma (SILO) FCF Margin (2019 - 2026) Analysis & Trends
Silo Pharma has reported FCF Margin for 8 years, with the latest figure at 4563.54% in Q1 2026.
- Quarterly FCF Margin rose 453610.0% year-over-year to 4563.54% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5330.87% (up 109896.0% YoY) and the FY2025 annual result came in at 6464.92%, down 114758.0% from the prior year.
- FCF Margin eased to 4563.54% in Q1 2026 per SILO's latest filing, from 4328.63% in the prior quarter.
- Over five years, FCF Margin peaked at 2219.74% in Q2 2022 and troughed at 9099.63% in Q1 2025.
- A 5-year average of 5287.94% and a median of 4981.7% in 2022 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2025 and 2026: FCF Margin plunged 444980 bps in 2025, then surged 453610 bps in 2026.
- Over 5 years, FCF Margin stood at 4915.06% in 2022, then slipped by 3 bps to 5048.33% in 2023, then slipped by 1 bps to 5089.49% in 2024, then increased by 15 bps to 4328.63% in 2025, then fell by 5 bps to 4563.54% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 4563.54%, 4328.63%, and 5300.93% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,563.54% |
| Dec 31, 2025 | -4,328.63% |
| Sep 30, 2025 | -5,300.93% |
| Jun 30, 2025 | -7,130.47% |
| Mar 31, 2025 | -9,099.63% |
| Dec 31, 2024 | -5,089.49% |
| Sep 30, 2024 | -7,470.18% |
| Jun 30, 2024 | -4,059.93% |
| Mar 31, 2024 | -4,649.83% |
| Dec 31, 2023 | -5,048.33% |
| Sep 30, 2023 | -5,946.36% |
| Jun 30, 2023 | -3,051.13% |
| Mar 31, 2023 | -3,842.72% |
| Dec 31, 2022 | -4,915.06% |
| Sep 30, 2022 | -7,891.03% |
| Jun 30, 2022 | -2,219.74% |
| Jun 30, 2021 | -766.31% |
| Mar 31, 2021 | -673.20% |
| Dec 31, 2020 | -2,423.73% |
| Sep 30, 2020 | -1,723.16% |